ArticleFEBS open bio2020
Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells.
Bo Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleFEBS open bio2020
Bo Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.